High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation

Venous thromboembolism (VTE) is a major burden in patients with BCR-ABL -negative myeloproliferative neoplasms (MPN). In addition to cytoreductive treatment anticoagulation is mandatory, but optimal duration of anticoagulation is a matter of debate. In our single center study, we retrospectively inc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of hematology 2019-01, Vol.98 (1), p.93-100
Hauptverfasser:	Wille, Kai, Sadjadian, Parvis, Becker, Tatjana, Kolatzki, Vera, Horstmann, Anette, Fuchs, Christiane, Griesshammer, Martin
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood cancer Hematology Medicine Medicine & Public Health Oncology Original Article Patients Thromboembolism Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!